BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18178251)

  • 1. Adenosine, through the A1 receptor, inhibits vesicular MHC class I cross-presentation by resting DC.
    Chen L; Fredholm BB; Jondal M
    Mol Immunol; 2008 Apr; 45(8):2247-54. PubMed ID: 18178251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
    Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
    Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC.
    Chen L; Jondal M
    Mol Immunol; 2008 Nov; 46(1):158-65. PubMed ID: 18723224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.
    Maurer T; Heit A; Hochrein H; Ampenberger F; O'Keeffe M; Bauer S; Lipford GB; Vabulas RM; Wagner H
    Eur J Immunol; 2002 Aug; 32(8):2356-64. PubMed ID: 12209649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells.
    Chen L; Jondal M
    Eur J Immunol; 2004 Apr; 34(4):952-60. PubMed ID: 15048705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG oligodeoxynucleotides enhance FcgammaRI-mediated cross presentation by dendritic cells.
    Bevaart L; Van Ojik HH; Sun AW; Sulahian TH; Leusen JH; Weiner GJ; Van De Winkel JG; Van Vugt MJ
    Int Immunol; 2004 Aug; 16(8):1091-8. PubMed ID: 15192052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
    Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
    Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of Brefeldin A during dendritic cell isolation allows in vitro detection of cross-presented self-antigens.
    Benke D; Krüger T; Lang A; Hamilton-Williams EE; Kurts C
    J Immunol Methods; 2006 Mar; 310(1-2):12-9. PubMed ID: 16510151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting to static endosome is required for efficient cross-presentation of endoplasmic reticulum-resident oxygen-regulated protein 150-peptide complexes.
    Kutomi G; Tamura Y; Okuya K; Yamamoto T; Hirohashi Y; Kamiguchi K; Oura J; Saito K; Torigoe T; Ogawa S; Hirata K; Sato N
    J Immunol; 2009 Nov; 183(9):5861-9. PubMed ID: 19812200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.
    O'Beirne J; Mitchell J; Farzaneh F; Harrison PM
    Virology; 2009 Jun; 389(1-2):1-7. PubMed ID: 19409594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells.
    Han S; Song Y; Lee YH; Lee YR; Lee CK; Cho K; Kim K
    Cytokine; 2005 Dec; 32(5):187-93. PubMed ID: 16303313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced generation of cytotoxic T lymphocytes by increased cytosolic delivery of MHC class I epitope fused to mouse heat shock protein 70 via polyhistidine conjugation.
    Takemoto S; Nishikawa M; Otsuki T; Yamaoka A; Maeda K; Ota A; Takakura Y
    J Control Release; 2009 Apr; 135(1):11-8. PubMed ID: 19100299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells.
    Shakushiro K; Yamasaki Y; Nishikawa M; Takakura Y
    Immunology; 2004 Jun; 112(2):211-8. PubMed ID: 15147564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 3 promotes cross-priming to virus-infected cells.
    Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Reis e Sousa C
    Nature; 2005 Feb; 433(7028):887-92. PubMed ID: 15711573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endolysosomal processing of exogenous antigen into major histocompatibility complex class I-binding peptides.
    Chen L; Jondal M
    Scand J Immunol; 2004 Jun; 59(6):545-52. PubMed ID: 15182249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8- dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens.
    Backer R; van Leeuwen F; Kraal G; den Haan JM
    Eur J Immunol; 2008 Feb; 38(2):370-80. PubMed ID: 18200498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.